Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature. 2007;449:804–810.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cao Y, Xia H, Tan X, Shi C, Ma Y, Meng D, et al. Intratumoural microbiota: a new frontier in cancer development and therapy. Signal Transduct Target Ther. 2024;9:15.

Article  PubMed  PubMed Central  Google Scholar 

Helmink BA, Khan MAW, Hermann A, Gopalakrishnan V, Wargo JA. The microbiome, cancer, and cancer therapy. Nat Med. 2019;25:377–88.

Article  CAS  PubMed  Google Scholar 

Oliva M, Mulet-Margalef N, Ochoa-De-Olza M, Napoli S, Mas J, Laquente B, et al. Tumor-associated microbiome: where do we stand? Int J Mol Sci. 2021;22:1446.

Goodwin CS. Helicobacter pylori: 10th anniversary of its culture in April 1982. Gut. 1993;34:293–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wilson MR, Jiang Y, Villalta PW, Stornetta A, Boudreau PD, Carrá A, et al. The human gut bacterial genotoxin colibactin alkylates DNA. Science. 2019;363:eaar7785.

Nejman D, Livyatan I, Fuks G, Gavert N, Zwang Y, Geller LT, et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science. 2020;368:973–80.

Article  CAS  PubMed  PubMed Central  Google Scholar 

France MM, Turner JR. The mucosal barrier at a glance. J Cell Sci. 2017;130:307–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi N, Li N, Duan X, Niu H. Interaction between the gut microbiome and mucosal immune system. Mil Med Res. 2017;4:14.

PubMed  PubMed Central  Google Scholar 

Rana N, Privitera G, Kondolf HC, Bulek K, Lechuga S, De Salvo C, et al. GSDMB is increased in IBD and regulates epithelial restitution/repair independent of pyroptosis. Cell. 2022;185:283–298.e217.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yao Y, Kim G, Shafer S, Chen Z, Kubo S, Ji Y, et al. Mucus sialylation determines intestinal host-commensal homeostasis. Cell. 2022;185:1172–1188.e1128.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vancamelbeke M, Vermeire S. The intestinal barrier: a fundamental role in health and disease. Expert Rev Gastroenterol Hepatol. 2017;11:821–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meddings J. The significance of the gut barrier in disease. Gut. 2008;57:438–40.

Article  PubMed  Google Scholar 

Li R, Shen J, Xu Y. Fusobacterium nucleatum and colorectal cancer. Infect drug resistance. 2022;15:1115–20.

Article  CAS  Google Scholar 

Gao Y, Bi D, Xie R, Li M, Guo J, Liu H, et al. Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer. Signal Transduct Target Ther. 2021;6:398.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang N, Fang JY. Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer. Trends Microbiol. 2023;31:159–72.

Article  CAS  PubMed  Google Scholar 

Abed J, Emgård JE, Zamir G, Faroja M, Almogy G, Grenov A, et al. Fap2 mediates Fusobacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed Gal-GalNAc. Cell Host Microbe. 2016;20:215–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen H, Ma Y, Xu J, Wang W, Lu H, Quan C, et al. Circulating microbiome DNA as biomarkers for early diagnosis and recurrence of lung cancer. Cell Rep. Med. 2024;5:101499.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xie Y, Xie F, Zhou X, Zhang L, Yang B, Huang J, et al. Microbiota in tumors: from understanding to application. Adv. Sci. (Weinh, Baden-Wurtt, Ger). 2022;9:e2200470.

Google Scholar 

Aykut B, Pushalkar S, Chen R, Li Q, Abengozar R, Kim JI, et al. The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL. Nature. 2019;574:264–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cummins J, Tangney M. Bacteria and tumours: causative agents or opportunistic inhabitants? Infect Agents Cancer. 2013;8:11.

Article  Google Scholar 

Poore GD, Kopylova E, Zhu Q, Carpenter C, Fraraccio S, Wandro S, et al. Microbiome analyses of blood and tissues suggest cancer diagnostic approach. Nature. 2020;579:567–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cullin N, Azevedo Antunes C, Straussman R, Stein-Thoeringer CK, Elinav E. Microbiome and cancer. Cancer cell. 2021;39:1317–41.

Article  CAS  PubMed  Google Scholar 

Larsen BD, Benada J, Yung PYK, Bell RAV, Pappas G, Urban V, et al. Cancer cells use self-inflicted DNA breaks to evade growth limits imposed by genotoxic stress. Science. 2022;376:476–83.

Article  CAS  PubMed  Google Scholar 

Huang R, Zhou PK. DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy. Signal Transduct Target Ther. 2021;6:254.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Basu AK. DNA damage, mutagenesis and cancer. Int J Mol Sci. 2018;19:970.

Wang X, Allen TD, May RJ, Lightfoot S, Houchen CW, Huycke MM. Enterococcus faecalis induces aneuploidy and tetraploidy in colonic epithelial cells through a bystander effect. Cancer Res. 2008;68:9909–17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barrett M, Hand CK, Shanahan F, Murphy T, O’Toole PW. Mutagenesis by microbe: the role of the microbiota in shaping the cancer genome. Trends cancer. 2020;6:277–87.

Article  CAS  PubMed  Google Scholar 

Putze J, Hennequin C, Nougayrède JP, Zhang W, Homburg S, Karch H, et al. Genetic structure and distribution of the colibactin genomic island among members of the family Enterobacteriaceae. Infect Immun. 2009;77:4696–703.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E, Nougayrède JP. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci USA. 2010;107:11537–42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goodwin AC, Destefano Shields CE, Wu S, Huso DL, Wu X, Murray-Stewart TR, et al. Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc Natl Acad Sci USA. 2011;108:15354–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cao Y, Wang Z, Yan Y, Ji L, He J, Xuan B, et al. Enterotoxigenic Bacteroidesfragilis Promotes Intestinal Inflammation and Malignancy by Inhibiting Exosome-Packaged miR-149-3p. Gastroenterology. 2021;161:1552–1566.e1512.

Article  CAS  PubMed  Google Scholar 

Allen J, Hao S, Sears CL, Timp W. Epigenetic changes induced by Bacteroides fragilis toxin. Infection Immunity 2019;87:e00447-18.

Valguarnera E, Wardenburg JB. Good gone bad: one toxin away from disease for Bacteroides fragilis. J Mol Biol. 2020;432:765–85.

Article